Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A | Zendy

Xiang Gao | Zendy; Zhang | Zendy; Gou | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A

Author(s) -

Xiang Gao,

Zhang,

Gou

Publication year - 2011

Publication title -

international journal of nanomedicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.245

H-Index - 128

eISSN - 1178-2013

pISSN - 1176-9114

DOI - 10.2147/ijn.s23582

Subject(s) - survivin , in vivo , transfection , in vitro , genetic enhancement , cancer research , apoptosis , cancer , pharmacology , biology , microbiology and biotechnology , medicine , gene , biochemistry

Gene therapy provides a novel method for the prevention and treatment of cancer, but the clinical application of gene therapy is restricted, mainly because of the absence of an efficient and safe gene delivery system. Recently, we developed a novel nonviral gene carrier, ie, heparin-polyethyleneimine (HPEI) nanoparticles for this purpose.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research